Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Iy 81149
2. Iy-81149
3. Iy81149
1. 172152-36-2
2. Iy-81149
3. Noltec
4. Iy 81149
5. Ilaprazole [inn]
6. Iy81149
7. 2-[(4-methoxy-3-methylpyridin-2-yl)methylsulfinyl]-6-pyrrol-1-yl-1h-benzimidazole
8. 2-(((4-methoxy-3-methylpyridin-2-yl)methyl)sulfinyl)-6-(1h-pyrrol-1-yl)-1h-benzo[d]imidazole
9. 776q6xx45j
10. 2-[(4-methoxy-3-methyl-pyridin-2-yl)methylsulfinyl]-5-pyrrol-1-yl-3h-benzoimidazole
11. Aldenon
12. 1h-benzimidazole,2-[[(4-methoxy-3-methyl-2-pyridinyl)methyl]sulfinyl]-5-(1h-pyrrol-1-yl)- (9ci)
13. 2-((rs)-((4-methoxy-3-methylpyridin-2-yl)methyl)sulfinyl)-5-(1h-pyrrol-1-yl)-1h-benzimidazole
14. Unii-776q6xx45j
15. Ilaprazole [mart.]
16. Ilaprazole [who-dd]
17. Schembl1179039
18. Chembl2106370
19. Gtpl10512
20. Dtxsid10870115
21. Chebi:135544
22. Amy42072
23. Bcp08220
24. Xga15236
25. Iy81149;iy 81149;ilaprazole
26. S3666
27. Akos025401705
28. Ccg-268243
29. Cs-6444
30. Db11964
31. 2-[[(4-methoxy-3-methyl-2-pyridinyl)methyl]sulfinyl]-6-(1h-pyrrol-1-yl)-1h-benzimidazole
32. Iy 81149iy81149
33. Ac-24701
34. Bs-15650
35. Db-064841
36. Hy-101664
37. Ft-0704889
38. Q15051261
39. 2-[(4-methoxy-3-methyl-pyridin-2-yl)methylsulfinyl]-6-pyrrol-1-yl-1h-benzoimidazole
40. 2-[(4-methoxy-3-methylpyridin-2-yl)methylsulfinyl]-5-pyrrol-1-yl-3h-benzoimidazole
41. 2-{[(4-methoxy-3-methylpyridin-2-yl)methyl]sulfinyl}-5-(1h-pyrrol-1-yl)-1h-benzimidazole
Molecular Weight | 366.4 g/mol |
---|---|
Molecular Formula | C19H18N4O2S |
XLogP3 | 2.3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 5 |
Exact Mass | 366.11504700 g/mol |
Monoisotopic Mass | 366.11504700 g/mol |
Topological Polar Surface Area | 92 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 502 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
A Ilaprazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ilaprazole, including repackagers and relabelers. The FDA regulates Ilaprazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ilaprazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ilaprazole manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ilaprazole supplier is an individual or a company that provides Ilaprazole active pharmaceutical ingredient (API) or Ilaprazole finished formulations upon request. The Ilaprazole suppliers may include Ilaprazole API manufacturers, exporters, distributors and traders.
click here to find a list of Ilaprazole suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ilaprazole Drug Master File in Korea (Ilaprazole KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ilaprazole. The MFDS reviews the Ilaprazole KDMF as part of the drug registration process and uses the information provided in the Ilaprazole KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ilaprazole KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ilaprazole API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ilaprazole suppliers with KDMF on PharmaCompass.
A Ilaprazole written confirmation (Ilaprazole WC) is an official document issued by a regulatory agency to a Ilaprazole manufacturer, verifying that the manufacturing facility of a Ilaprazole active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ilaprazole APIs or Ilaprazole finished pharmaceutical products to another nation, regulatory agencies frequently require a Ilaprazole WC (written confirmation) as part of the regulatory process.
click here to find a list of Ilaprazole suppliers with Written Confirmation (WC) on PharmaCompass.
Ilaprazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ilaprazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ilaprazole GMP manufacturer or Ilaprazole GMP API supplier for your needs.
A Ilaprazole CoA (Certificate of Analysis) is a formal document that attests to Ilaprazole's compliance with Ilaprazole specifications and serves as a tool for batch-level quality control.
Ilaprazole CoA mostly includes findings from lab analyses of a specific batch. For each Ilaprazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ilaprazole may be tested according to a variety of international standards, such as European Pharmacopoeia (Ilaprazole EP), Ilaprazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ilaprazole USP).
LOOKING FOR A SUPPLIER?